CA2451663A1 - Method and device for subretinal drug delivery - Google Patents

Method and device for subretinal drug delivery Download PDF

Info

Publication number
CA2451663A1
CA2451663A1 CA002451663A CA2451663A CA2451663A1 CA 2451663 A1 CA2451663 A1 CA 2451663A1 CA 002451663 A CA002451663 A CA 002451663A CA 2451663 A CA2451663 A CA 2451663A CA 2451663 A1 CA2451663 A1 CA 2451663A1
Authority
CA
Canada
Prior art keywords
piercing member
cannula
distal end
eye
length
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002451663A
Other languages
French (fr)
Other versions
CA2451663C (en
Inventor
Signe Erickson Varner
Eugene Dejuan Jr.
Terry Harrison Shelley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2451663A1 publication Critical patent/CA2451663A1/en
Application granted granted Critical
Publication of CA2451663C publication Critical patent/CA2451663C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Devices and devices for the treatment of the eye are disclosed. Preferred devices of the invention include a piercing member (12) that is inserted into the eye to create a pathway for a cannula(44). The cannula (44) is slidably mounted to the piercing member (12) and is adapted to reach a treatment site within the eye at which material is injected into and/or withdrawn from the eye. The outer diameter of the piercing member (12) is small enough to allow for self-sealing of the insertion site of the device upon the device's withdrawal therefrom. Also disclosed are methods for the utilizing the devices to treat the eye.

Claims (35)

  1. What is claimed is:
    A device for treating an eye, comprising:
    a piercing member having a length and an outer diameter, the piercing member having proximal end and a distal end and a lumen extending therebetween, the distal end being of sufficient sharpness to penetrate an insertion site of the device;
    and a cannula slidably insertable within the piercing member, the cannula having a length longer than the length of the piercing member and having a distal end of sufficient sharpness to penetrate a treatment site, wherein the outer diameter of the piercing member is small enough to allow for self sealing of the insertion site upon removal of the piercing member from the insertion site.
  2. 2. A device for treating an eye, comprising a piercing member and a cannula insertable within the piercing member, the cannula having a length longer than the length of the piercing member.
  3. 3. The device of claim 1 or 2 further comprising:
    a handle having a length, a proximal end and a distal end and a lumen extending therebetween, the distal end of the handle being mounted to the piercing member, and the handle lumen being sized to accommodate the cannula.
  4. 4. The device of any one of claims 1 through 3 wherein the distal end of the piercing member is beveled.
  5. 5. The device of any one of claims 1 through 4 wherein the outer diameter of the piercing member is about 25 gage.
  6. 6. The device of any one of claims 1 or 3 through 5 wherein the length of the piercing member is in the range of about 6 millimeters to 40 millimeters, the length of the cannula is in the range of about 35 millimeters to 75 millimeters, and the length of the reduced diameter distal portion of the cannula is in the range of about 1 millimeter to 3 millimeters.
  7. 7. The device of any one of claims 1 through G wherein the piercing member is made of a stainless steel.
  8. 8. The device of any one of claims 1 through 7 wherein the cannula is made of polyimide tubing.
  9. 9. The device of any one of claims 1 through 8 wherein the device is adapted for subretinal delivery of a therapeutic agent to a patient's eye.
  10. 10. A device for treating an eye, comprising:
    a piercing member having a length and an outer diameter, the piercing member having proximal end and a distal end and a lumen extending therebetween, the distal end being of sufficient sharpness to penetrate an insertion site of the device;
    a rigid member disposed within the piercing member lumen and having a proximal end and a distal end and a lumen extending therebetween, the rigid member having a length greater than the length of the piercing member;
    a cannula disposed within and connected to rigid member lumen, the cannula having a length longer than the length of each of the piercing member and the rigid member, and having a distal end of sufficient sharpness to penetrate a treatment site.
  11. 11. The device of claim 10 further comprising:
    a quantity of tubing having a proximal end and a distal end and a lumen extending therebetween, wherein the proximal end of the rigid member is disposed within and connected to the distal end of the tubing.
  12. 12. The device of claim 11 further comprising:
    a first connection element having a proximal end and a distal end and a lumen extending therebetween, the distal end of the first connection element being connected to the proximal end of the piercing element.
  13. 13. The device of claim 12 wherein the first connection element lumen and the piercing member lumen are substantially longitudinally aligned.
  14. 14. The device of claim 12 further comprising:
    a seal in communication with the first connection element such that the seal substantially surrounds at least a portion of the first connection element lumen.
  15. 15. The device of any one of claims 10 through 14 wherein the outer diameter of the piercing member is small enough to allow fox self sealing of the insertion site upon removal of the piercing member from the insertion site.
  16. 16. The device of any one of claims 10 through 14 wherein the distal end of the piercing member is beveled.
  17. 17. A device for treating an eye, comprising:
    a piercing member having a length and an outer diameter, the piercing member having proximal end and a distal end and a lumen extending therebetween, the distal end being of sufficient sharpness to penetrate an insertion site of the device;
    a handle having a length, a proximal end and a distal end and a substantially hollow portion, the distal end of the handle being mounted to the piercing member, and the handle lumen being sized to accommodate the outer diameter of the cannula;
    a quantity of tubing having a proximal end and a distal end and a lumen extending therebetween, the distal end of the tubing being disposed within the substantially hollow portion of the handle; and a cannula connected to, and disposed at least partially within the tubing lumen, the cannula having an outer diameter such that the cannula is substantially flush with the tubing lumen, and having a distal end of sufficient sharpness to penetrate a treatment site.
  18. 18. The device of claim 17 further comprising:

    a housing located within the substantially hollow portion of the handle, the housing being in communication with the distal end of the tubing; and an actuating element in communication with the housing, wherein distal-to-proximal and proximal-to-distal movement of the actuating element are effective to impart corresponding movement to the housing and the tubing.
  19. 19. The device of claim 17 or 18 wherein the distal end of the piercing member is beveled.
  20. 20. The device of any one of claims 17 through 19 wherein the outer diameter of the piercing member is small enough to allow for self sealing of the insertion site upon removal of the piercing member from the insertion site.
  21. 21. A medical device kit comprising one or more of the devices of any one of claims 1 through 20.
  22. 22. The kit of claim 21 wherein one or more of the device sare packaged in sterile condition.
  23. 23. A method for treating an eye comprising:
    inserting into an eye a device comprising a piercing member and a cannula insertable within the piercing member, the cannula having a length longer than the length of the piercing member.
  24. 24. The method of claim 23 wherein a therapeutic agent is administered to a patient's eye through the device.
  25. 25. The method of claim 23 wherein the therapeutic agent is administered subretinally to the patient's eye.
  26. 26. The method of any one of claims 23 through 25 wherein the maximum cross-sectional dimension of the portion of the device that pierces a patient's eye is about 25 gage or smaller.
  27. 27. A method of treating an eye, comprising:
    inserting a piercing member having an outer diameter into an insertion site, the piercing member having a proximal end and a distal end and a lumen defined therebetween;
    advancing a cannula through the piercing member lumen, the cannula having a proximal end and a distal end;
    guiding the cannula to a treatment site;
    treating the treatment site;
    withdrawing the cannula from the piercing member; and withdrawing the piercing member from the insertion site, wherein the outer diameter of the piercing member is small enough to allow the insertion site to self seal following withdrawal of the piercing member.
  28. 28. The method of claim 27 wherein the step of guiding the cannula to the treatment site comprises:
    advancing the cannula within the eye until the distal end of the cannula is within the treatment site.
  29. 29. The method of claim 27 or 28 wherein the step of treating the treatment site comprises:
    supplying a medicament through the cannula and into the treatment site via the distal end of the cannula.
  30. 30. The method of any one of claims 27 through 29 wherein the medicament is selected from the group consisting of genes, proteins, cells, small molecule pharmaceuticals and sterile solutions.
  31. 31. The method of any one of claims 27 through 30 wherein the step of treating the treatment site comprises withdrawing material from the treatment site into the distal end of the cannula.
  32. 32. The method of any one of claims 27 through 31 wherein the step of inserting the piercing member into the insertion site comprises inserting the distal end of the piercing member into and through the eye's sclera.
  33. 33. The method of any one of claims 27 through 32 wherein the treatment site is selected from the group consisting of the eye's retina and the eye's vitreous humor.
  34. 34. The method of any one of claims 27 through 33 wherein the treatment site is the eye's retina and the step of treating the treatment site comprises:
    injecting medicament through the cannula and into the retina such that a dome-shaped retinal detachment is formed.
  35. 35. The method of any one of claims 27 through 34 wherein the outer diameter of the piercing member is about 25 gage or smaller.
CA2451663A 2001-06-22 2002-06-21 Method and device for subretinal drug delivery Expired - Fee Related CA2451663C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/888,079 2001-06-22
US09/888,079 US7485113B2 (en) 2001-06-22 2001-06-22 Method for drug delivery through the vitreous humor
PCT/US2002/019899 WO2003000312A2 (en) 2001-06-22 2002-06-21 Method and device for subretinal drug delivery

Publications (2)

Publication Number Publication Date
CA2451663A1 true CA2451663A1 (en) 2003-01-03
CA2451663C CA2451663C (en) 2012-12-04

Family

ID=25392484

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2451663A Expired - Fee Related CA2451663C (en) 2001-06-22 2002-06-21 Method and device for subretinal drug delivery

Country Status (6)

Country Link
US (2) US7485113B2 (en)
EP (1) EP1404399A4 (en)
JP (1) JP4505219B2 (en)
AU (1) AU2002316350B2 (en)
CA (1) CA2451663C (en)
WO (1) WO2003000312A2 (en)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE547080T1 (en) * 2000-08-30 2012-03-15 Univ Johns Hopkins DEVICES FOR INTRAOCULAR DRUG DELIVERY
US7316676B2 (en) * 2002-08-20 2008-01-08 Gholam A. Peyman Treatment of retinal detachment
US20050143363A1 (en) * 2002-09-29 2005-06-30 Innorx, Inc. Method for subretinal administration of therapeutics including steroids; method for localizing pharmacodynamic action at the choroid of the retina; and related methods for treatment and/or prevention of retinal diseases
US7483750B2 (en) * 2003-03-21 2009-01-27 Second Sight Medical Products, Inc. Transretinal implant and method of implantation
CA2524271C (en) 2003-05-02 2012-09-04 Surmodics, Inc. Controlled release bioactive agent delivery device
US8246974B2 (en) 2003-05-02 2012-08-21 Surmodics, Inc. Medical devices and methods for producing the same
US20060110428A1 (en) * 2004-07-02 2006-05-25 Eugene Dejuan Methods and devices for the treatment of ocular conditions
DE102005009694B4 (en) * 2005-02-28 2007-05-03 Geuder Ag Ophthalmic set
WO2006110487A1 (en) 2005-04-08 2006-10-19 Surmodics, Inc. Sustained release implants for subretinal delivery
US20070027452A1 (en) * 2005-05-18 2007-02-01 Varner Signe E Insertion instrument for non-linear medical devices
US20070009564A1 (en) * 2005-06-22 2007-01-11 Mcclain James B Drug/polymer composite materials and methods of making the same
AU2006270221B2 (en) 2005-07-15 2012-01-19 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
WO2007011708A2 (en) 2005-07-15 2007-01-25 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
EP2019657B1 (en) 2006-04-26 2015-05-27 Micell Technologies, Inc. Coatings containing multiple drugs
JP4872081B2 (en) * 2006-06-01 2012-02-08 国立大学法人徳島大学 Vitreous surgery cannula
US9539593B2 (en) * 2006-10-23 2017-01-10 Micell Technologies, Inc. Holder for electrically charging a substrate during coating
EP2111184B1 (en) * 2007-01-08 2018-07-25 Micell Technologies, Inc. Stents having biodegradable layers
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
JP5443336B2 (en) * 2007-04-17 2014-03-19 ミセル テクノロジーズ、インコーポレイテッド Stent with biodegradable layer
CA2688314C (en) 2007-05-25 2013-12-03 Micell Technologies, Inc. Polymer films for medical device coating
US20090036827A1 (en) 2007-07-31 2009-02-05 Karl Cazzini Juxtascleral Drug Delivery and Ocular Implant System
WO2009051780A1 (en) * 2007-10-19 2009-04-23 Micell Technologies, Inc. Drug coated stents
US8353862B2 (en) * 2007-11-02 2013-01-15 Allergan, Inc. Drug delivery systems and methods
US8602959B1 (en) 2010-05-21 2013-12-10 Robert Park Methods and devices for delivery of radiation to the posterior portion of the eye
US9056201B1 (en) 2008-01-07 2015-06-16 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive delivery of radiation to the eye
US9873001B2 (en) 2008-01-07 2018-01-23 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive delivery of radiation to the eye
KR101634983B1 (en) * 2008-01-07 2016-07-01 살루타리스 메디컬 디바이스즈, 인코퍼레이티드 Methods and devices for minimally-invasive extraocular delivery of radiation to the posterior portion of the eye
US20110207987A1 (en) * 2009-11-02 2011-08-25 Salutaris Medical Devices, Inc. Methods And Devices For Delivering Appropriate Minimally-Invasive Extraocular Radiation
US8608632B1 (en) 2009-07-03 2013-12-17 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive extraocular delivery of radiation and/or pharmaceutics to the posterior portion of the eye
US10022558B1 (en) 2008-01-07 2018-07-17 Salutaris Medical Devices, Inc. Methods and devices for minimally-invasive delivery of radiation to the eye
MX350637B (en) * 2008-04-17 2017-09-11 Micell Technologies Inc Stents having bioabsorbable layers.
US20090318856A1 (en) * 2008-06-18 2009-12-24 Glaser Bert M Sampling Ocular Fluid
WO2010009335A1 (en) 2008-07-17 2010-01-21 Micell Technologies, Inc. Drug delivery medical device
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
US7730628B2 (en) * 2008-09-05 2010-06-08 Bayer Schering Pharma Ag Depth stop devices and systems
WO2010062394A2 (en) * 2008-11-26 2010-06-03 Surmodics, Inc. Implantable ocular drug delivery device and methods
US8834913B2 (en) * 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
NL2002379C2 (en) * 2008-12-29 2010-06-30 D O R C Dutch Ophthalmic Res Ct International B V An ophthalmic device and an intravitreal method.
USD691270S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to an eye
USD691267S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to eye
USD691268S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to eye
USD691269S1 (en) 2009-01-07 2013-10-08 Salutaris Medical Devices, Inc. Fixed-shape cannula for posterior delivery of radiation to an eye
EP2410954A4 (en) * 2009-03-23 2014-03-05 Micell Technologies Inc Peripheral stents having layers
WO2010111232A2 (en) 2009-03-23 2010-09-30 Micell Technologies, Inc. Drug delivery medical device
US8287494B2 (en) * 2009-03-23 2012-10-16 Colin Ma Intravitreal injection devices and methods of injecting a substance into the vitreous chamber of the eye
CN102481195B (en) * 2009-04-01 2015-03-25 米歇尔技术公司 Drug delivery medical device
CA2759015C (en) 2009-04-17 2017-06-20 James B. Mcclain Stents having controlled elution
EP2429607A4 (en) * 2009-05-15 2014-01-08 Iscience Interventional Corp Methods and apparatus for sub-retinal catheterization
JP2013501579A (en) * 2009-08-10 2013-01-17 サーモディクス，インコーポレイテッド Methods, devices and compositions for intravitreal injection
US20110166555A1 (en) * 2009-09-30 2011-07-07 Jianbo Zhou Carrier for an insertable medical device, insertion tools, methods of use, and kits
US20110112469A1 (en) * 2009-11-08 2011-05-12 Powerscope Incorporated Device and process for dispensing multiple-phase mixtures
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
EP2515774B1 (en) * 2009-12-23 2014-03-19 Alcon Research, Ltd. Ophthalmic valved trocar cannula
US8343106B2 (en) * 2009-12-23 2013-01-01 Alcon Research, Ltd. Ophthalmic valved trocar vent
WO2011097103A1 (en) * 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US8795762B2 (en) 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
US20130172853A1 (en) 2010-07-16 2013-07-04 Micell Technologies, Inc. Drug delivery medical device
US10285852B2 (en) * 2010-12-02 2019-05-14 Tel Hashomer Medical Research Infrastructure And Services Ltd., The Chaim Sheba Medical Center Subretinal delivery of therapeutic compositions
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
CA2841360A1 (en) 2011-07-15 2013-01-24 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
MX351261B (en) 2012-06-01 2017-10-06 Surmodics Inc Apparatus and method for coating balloon catheters.
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
US9757536B2 (en) 2012-07-17 2017-09-12 Novartis Ag Soft tip cannula
JP6084408B2 (en) * 2012-09-07 2017-02-22 Hoya株式会社 Surgical instruments
CN110269959A (en) 2013-03-12 2019-09-24 脉胜医疗技术公司 Bioabsorbable biomedical implants
US10272606B2 (en) 2013-05-15 2019-04-30 Micell Technologies, Inc. Bioabsorbable biomedical implants
EP3003235B1 (en) * 2013-05-31 2021-09-29 The Regents of The University of Colorado, A Body Corporate Devices for creating a predictable capsulorhexis of specific diameter
AU2015214381C1 (en) * 2014-02-06 2019-06-27 Alcon Inc. Manufacturing an articulating ophthalmic surgical probe
US9949874B2 (en) * 2014-06-06 2018-04-24 Janssen Biotech, Inc. Therapeutic agent delivery device with convergent lumen
US9925088B2 (en) * 2014-06-06 2018-03-27 Janssen Biotech, Inc. Sub-retinal tangential needle catheter guide and introducer
US10391206B2 (en) 2014-07-30 2019-08-27 University Of Kansas Cannula for external drainage of subretinal fluid
USD815285S1 (en) 2016-05-11 2018-04-10 Salutaris Medical Devices, Inc. Brachytherapy device
USD814638S1 (en) 2016-05-11 2018-04-03 Salutaris Medical Devices, Inc. Brachytherapy device
USD814637S1 (en) 2016-05-11 2018-04-03 Salutaris Medical Devices, Inc. Brachytherapy device
US10463532B2 (en) 2016-07-26 2019-11-05 Masatoshi Murata Method for placing implant in choroid that can less invasively and simply place implant in choroid in optic disc-macula area
USD808529S1 (en) 2016-08-31 2018-01-23 Salutaris Medical Devices, Inc. Holder for a brachytherapy device
USD808528S1 (en) 2016-08-31 2018-01-23 Salutaris Medical Devices, Inc. Holder for a brachytherapy device
WO2020112816A1 (en) 2018-11-29 2020-06-04 Surmodics, Inc. Apparatus and methods for coating medical devices
US11759355B1 (en) 2019-02-26 2023-09-19 Gyroscope Therapeutics Limited Method of delivering leading blebs and agent to subretinal space
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3598119A (en) 1970-02-02 1971-08-10 Charles A White Continuous paracervical anesthesia method and device
US3659610A (en) 1970-04-14 1972-05-02 Hugo S Cimber Aspirator needle injector
US4002169A (en) * 1972-04-18 1977-01-11 Cupler Ii John A Method and apparatus for performing surgery without tissue incision
CA1221596A (en) 1984-03-09 1987-05-12 David Evans Surgical needle
US4710171A (en) 1986-06-09 1987-12-01 The Kendall Company Needle depth setting sheath assembly and needle stop
US4781691A (en) 1987-07-17 1988-11-01 The Kendall Company Stepped needle
US4909784A (en) * 1988-03-25 1990-03-20 Seymour Dubroff Method for preventing clouding of posterior capsule after extracapsular cataract eye surgery
US4869717A (en) * 1988-04-25 1989-09-26 Adair Edwin Lloyd Gas insufflation needle with instrument port
US5066276A (en) 1988-06-21 1991-11-19 Alcon Laboratories, Inc. Method and apparatus for injecting viscous fluid into the eye to lift pre-retinal and post-retinal membrane with linear pressure control
US4978334A (en) 1988-09-08 1990-12-18 Toye Frederic J Apparatus and method for providing passage into body viscus
SG49267A1 (en) 1989-08-14 1998-05-18 Photogenesis Inc Surgical instrument and cell isolation and transplantation
JPH0399653A (en) 1989-09-13 1991-04-24 Terumo Corp Puncturing needle
US5273530A (en) 1990-11-14 1993-12-28 The University Of Rochester Intraretinal delivery and withdrawal instruments
JP2660455B2 (en) * 1991-02-08 1997-10-08 東洋鋼鈑株式会社 Heat resistant hard sintered alloy
US5326345A (en) 1991-08-14 1994-07-05 Price Jr Francis W Eye filtration prostheses
WO1994011042A1 (en) 1992-11-10 1994-05-26 Seikagaku Kogyo Kabushiki Kaisha Injector and use of the same
US5487725A (en) 1994-05-12 1996-01-30 Syntec, Inc. Pneumatic vitrectomy for retinal attachment
US5792099A (en) 1995-02-14 1998-08-11 Decamp; Dennis Syringe and cannula for insertion of viscoelastic material into an eye and method of using same
US6824553B1 (en) * 1995-04-28 2004-11-30 Target Therapeutics, Inc. High performance braided catheter
JPH1085331A (en) * 1996-07-26 1998-04-07 Asahi Optical Co Ltd Injection tool for endoscope
US5984889A (en) 1996-02-23 1999-11-16 Allergan Sales, Inc. Apparatus and method for delivering viscoelastic material to an eye
US5989262A (en) * 1996-04-15 1999-11-23 Josephberg; Robert Gary Sutureless pars plana vitrectomy tool
AUPO394496A0 (en) 1996-11-29 1997-01-02 Lions Eye Institute Biological microfistula tube and implantation method and apparatus
US5871470A (en) 1997-04-18 1999-02-16 Becton Dickinson And Company Combined spinal epidural needle set
DE19725680C2 (en) 1997-06-18 2000-04-06 Hans Haindl Funnel-shaped cannula arrangement for catheter insertion
US5997486A (en) * 1998-04-24 1999-12-07 Denver Biomaterials, Inc. Device for paracentisis and thoracentisis
US6402734B1 (en) 1998-07-02 2002-06-11 Jeffrey N. Weiss Apparatus and method for cannulating retinal blood vessels
US6024719A (en) * 1998-07-06 2000-02-15 Morris; Robert E Method and apparatus for performing surgery inside the human retina using fluidic internal limiting membrane (ILM) seperation (FILMS)
US6309374B1 (en) * 1998-08-03 2001-10-30 Insite Vision Incorporated Injection apparatus and method of using same
US6378526B1 (en) * 1998-08-03 2002-04-30 Insite Vision, Incorporated Methods of ophthalmic administration
US6585972B2 (en) * 1999-03-09 2003-07-01 Gholam A. Peyman Process for crosslinking of collagen in the vitreous of the eye and inducing separation of the posterior hyaloid from the retina
US6319230B1 (en) * 1999-05-07 2001-11-20 Scimed Life Systems, Inc. Lateral needle injection apparatus and method
US6428553B1 (en) * 2000-03-08 2002-08-06 Nuvue Technologies, Inc. Illuminated ophthalmic membrane pick assembly
US6641564B1 (en) * 2000-11-06 2003-11-04 Medamicus, Inc. Safety introducer apparatus and method therefor
US20030171722A1 (en) * 2001-01-04 2003-09-11 Michel Paques Microsurgical injection and/or distending instruments and surgical method and apparatus utilizing same
US7122042B2 (en) * 2001-03-15 2006-10-17 Lorusso Frank J Apparatuses and methods for transcleral cautery and subretinal drainage
US20030158521A1 (en) 2002-02-21 2003-08-21 Ameri Darius M. Trocar placement guide needle

Also Published As

Publication number Publication date
WO2003000312A3 (en) 2003-11-06
US20080154204A1 (en) 2008-06-26
AU2002316350B2 (en) 2008-06-05
EP1404399A2 (en) 2004-04-07
US20020198511A1 (en) 2002-12-26
EP1404399A4 (en) 2008-07-23
JP2005516636A (en) 2005-06-09
US7485113B2 (en) 2009-02-03
WO2003000312A2 (en) 2003-01-03
JP4505219B2 (en) 2010-07-21
CA2451663C (en) 2012-12-04

Similar Documents

Publication Publication Date Title
CA2451663A1 (en) Method and device for subretinal drug delivery
US6402734B1 (en) Apparatus and method for cannulating retinal blood vessels
AU742031B2 (en) Catheter system for administration of continuous peripheral nerve anesthetic
JP2519873B2 (en) A catheter / needle assembly and kit for injecting therapeutic agents into the subarachnoid cavity
US6936053B1 (en) Ocular implant needle
US6120492A (en) Method and apparatus for percutaneously accessing an implanted port
US8029495B2 (en) Intrathecal catheter having a stylet with a curved tip and method of use
AU2002316350A1 (en) Method and device for subretinal drug delivery
US6863662B2 (en) Intravenous infusion needle with soft body
EP2222355B1 (en) Meibomian gland intraductal diagnostic and treatment methods and related apparatus
US20080108971A1 (en) Infiltration cannula
JPH05505733A (en) Anesthesia induction method and device
US20030135153A1 (en) Drug implant injection device
US20050283124A1 (en) Needle with slotted tip
EP0614676B1 (en) Catheter apparatus for delivering drugs to the penis
EP2247270B1 (en) Needle for ophthalmic procedures
CN101703417A (en) Fenestrated peripheral nerve block needle and method for using the same
US20030229321A1 (en) Needle with slotted tip
JP3685509B2 (en) Cap for subcutaneous implantable liquid injection port sleeve
JP2002500072A (en) Method and apparatus for disinfecting a subcutaneous implant device
US5199946A (en) Device and method for administering interpleural anesthesia
CN218943684U (en) Eye is through ball back injection needle under ten's bag
JPH08150213A (en) Gene injector
RU204832U1 (en) Intraosseous access device
EP2679268A1 (en) Infusion catheter system

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20150622